Johnson & Johnson Consumer Companies, Inc.
199 Grandview Road
10 articles with Johnson & Johnson Consumer Companies, Inc.
Johnson & Johnson Consumer Health Unveils New Skin Health Research at 2022 American Academy of Dermatology Meeting
Johnson & Johnson Consumer Inc. will present new research highlighting important advances in the understanding and treatment of skin at the 2022 American Academy of Dermatology (AAD) Meeting.
According to CNN, Califf is being vetted by the administration of Joe Biden, who served as vice president to Obama.
BioSpace takes an in-depth look at the Top 25 of Q1. You should be aware of these biopharma companies as they hold a great future ahead. So, check them out.
Johnson & Johnson Consumer Inc. reaffirmed that its Johnson's Baby Powder is safe and free of asbestos after a comprehensive investigation into the United States Food and Drug Administration's earlier reported finding of sub-trace levels of asbestos in samples from a single bottle of Johnson's Baby Powder.
Johnson & Johnson Consumer Inc. To Voluntarily Recall A Single Lot Of Johnson's Baby Powder In The United States
Out of an abundance of caution, Johnson & Johnson Consumer Inc. announced that it is initiating a voluntary recall in the United States of a single lot of its Johnson's Baby Powder in response to a U.S. Food and Drug Administration test indicating the presence of sub-trace levels of chrysotile asbestos contamination in samples from a single bottle purchased from an online retailer.
Holobiome Announces Second Collaboration with Johnson & Johnson Innovation to Create Novel Microbiome Therapeutics
Holobiome, a biotechnology company developing microbiome therapeutics that target the gut-brain-axis, announces a research collaboration with Johnson & Johnson Consumer Inc.
Johnson & Johnson Consumer Highlights Innovation in Skin Science at 2019 American Academy of Dermatology Annual Meeting
Johnson & Johnson Consumer Inc. will present a diverse portfolio of scientific research across skin and hair physiology at this year's American Academy of Dermatology (AAD) Annual Meeting in Washington, DC. including 13 Scientific ePosters and a preview of the latest innovations in beauty technology.
The transaction is expected to close during the third quarter of 2018.
Johnson & Johnson Consumer Companies, Inc., Showcases CYTOMIMIC(TM) Technology at 69th Annual Meeting of the American Academy of Dermatology
Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology